Cash on hold, but stem cell work on [California]
By Rebecca Vesely,
Oakland Tribune
| 01. 17. 2006
Agency president vows to push ahead with research despite lawsuits
Beset by legal woes, California's stem cell institute likely won't see voter-approved funds for another 15 months, yet its president said support for scientific research will continue.
"We are not going into hibernation," said Zach Hall, president of the California Institute for Regenerative Medicine. "I am personally determined that we will remain active this year."
In an interview at CIRM's new headquarters in San Francisco overlooking SBC Park, Hall said in 2006 the agency plans to finalize academic and scientific standards, hold several conferences and issue nearly $40 million in training grants announced in the fall.
To do this, and keep administrative operations going, including paying the salaries of 18 staff members, will take a little creative financing, using a combination of loans totalling about $52 million.
As things stand today, the landmark agency that voters in November 2004 overwhelmingly chose to underwrite with $3 billion over 10 years, is set to run out of money June 30.
A lawsuit filed in Alameda County Superior Court bygroups morally opposed toembryonic...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...